CNS Lymphoma
CA-4948 IN RELAPSED OR REFRACTORY PRIMARY CNS LYMPHOMA
An open-label, dose escalation and dose expansion trial to evaluate emavusertib (CA-4948) in adult patients with relapsed or refractory primary central nervous system lymphoma.
Learn More